Targeting HOX and PBX transcription factors in ovarian cancer
-
* Corresponding author: Richard Morgan r.morgan@surrey.ac.uk
BMC Cancer 2010, 10:89 doi:10.1186/1471-2407-10-89
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 11 Mar 2009 | |
| Reviewer's Report | Barbara Vanderhyden | 14 Apr 2009 | |
| Reviewer's Report | Arthur McKie | 22 Apr 2009 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 02 Jun 2009 |
| Resubmission - Version 3 | Manuscript | 04 Jun 2009 | |
| Reviewer's Report | Arthur McKie | 15 Jun 2009 | |
| Reviewer's Report | Barbara Vanderhyden | 21 Jun 2009 | |
| Reviewer's Report | Brian Egleston | 30 Jun 2009 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 15 Oct 2009 |
| Reviewer's Report | Brian Egleston | 29 Oct 2009 | |
| Resubmission - Version 5 | Manuscript | Author's comment | 10 Dec 2009 |
| Resubmission - Version 6 | Manuscript | 10 Dec 2009 | |
| Reviewer's Report | Brian Egleston | 26 Jan 2010 | |
| Editorial acceptance | 05 Feb 2010 | ||
| Published | 10 Mar 2010 |